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Figure 1. Representative MarR homologs and their mode of gene regulation.
(A) Structure of MTH313 (3BPX), a MarR homolog of unknown function from Methanobacte-
rium thermoautotrophicum, in complex with the ligand salicylate (shown in magenta). One 
monomer is shown in gray, the other is colored from amino to carboxyl terminus (blue to red). 
Note the asymmetrical ligand binding; only ligand binding at the primary site (at the right) is 
associated with protein conformational changes and is therefore considered physiologically 
relevant. (B) Structure of Deinococcus radiodurans HucR (2FBK). Each monomer is shown in 
light and dark blue. HucR includes an amino-terminal extension conserved among a subset of 
MarR homologs (shown in orange) that is not seen in other reported MarR protein structures. 
DNA recognition helices are colored green and residues required for binding of the ligand urate 
are shown in magenta. (C) Structure of Staphylococcus epidermidis TcaR (3KP5) in complex 
with kanamycin (shown in magenta). Note that the symmetry-related site is unoccupied. Each 
monomer is shown in light and dark blue, with the DNA recognition helices in green. (D) Struc-
ture of oxidized OhrR from Xanthomonas campestris (2PFB). Each monomer is shown in light 
and dark blue with oxidized cysteines in orange. (E) Typical organization of genomic locus 
comprising gene encoding MarR homolog. Genes are depicted as blue arrows. The intergenic 
region between divergently encoded genes contains cognate DNA site(s). (F) In the absence 
of ligand, the MarR homolog (green symbol) binds the intergenic region, repressing expression 
of both genes. In the presence of ligand, DNA binding is attenuated and genes are expressed.MarR family 
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What are MarR proteins? Members 
of the Multiple Antibiotic Resistance 
Regulator (MarR) family of 
transcriptional regulators are named 
for Escherichia coli MarR. In E. coli, 
MarR regulates an operon that 
encodes a drug efflux pump, and 
mutations in proteins that participate 
in this system lead to a multiple 
antibiotic resistance phenotype, 
hence the name. MarR proteins are 
members of the winged helix-turn-
helix family of transcription factors.
Where are they? MarR proteins are 
encoded by bacteria and archaea, and 
their abundance typically correlates 
with a free-living lifestyle and large 
genome size. In general, obligate 
parasitic species feature reduced 
genome sizes and encode fewer 
transcription factors while organisms 
with complex lifestyles (such as 
species with both free-living and 
parasitic or symbiotic stages) encode 
numerous transcriptional regulators, 
including MarR homologs. Consistent 
with this trend, MarR homologs serve 
physiological roles as sensors of 
changing environments.
How do they regulate gene 
expression? While some MarR 
homologs activate transcription, most 
repress gene activity. A genomic locus 
consisting of divergently oriented 
genes encoding the MarR homolog 
and the gene(s) under its control is 
common (Figure 1). This layout allows 
the transcription factor to bind site-
specifically to the intergenic regions 
between divergently transcribed 
genes to repress transcription 
of both. On binding of a small 
molecule ligand or in response to 
oxidation of specific cysteines, DNA 
binding is attenuated, resulting in 
activated gene expression. This 
general mechanism also results in 
the expression of MarR proteins 
being autoregulatory; as the cellular 
concentration of the MarR protein 
increases, negative autoregulation 
shuts off further transcription of the 
Quick guide marR gene and prevents excessive protein accumulation. The advantage 
of this mechanism is that the MarR 
protein concentration fluctuates 
within a narrow range that allows a 
more sensitive response to ligands. In addition to adjacent genes, distant 
genes may also be regulated by a 
given homolog. 
Many MarR homologs bind 
cognate sites that overlap the -10 
and -35 promoter elements. However, 
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repression beyond competition for 
RNA polymerase binding have also 
been proposed, including hindering 
transcriptional elongation and 
competing with other transcriptional 
regulators.
What signals do they respond to 
and what genes do they regulate? 
Generally, MarR homologs regulate 
activity of genes involved in stress 
responses, virulence, or degradation 
or export of harmful chemicals such 
as phenolic compounds, antibiotics, 
and common household detergents. 
E. coli MarR (the namesake of the 
protein family) regulates resistance 
to organic solvents, disinfectants, 
detergents, oxidative stress, and 
antibiotics. In general, homologs 
that regulate drug efflux pumps may 
bind antibiotics or other substrates 
for the associated efflux system. 
MarR homologs may also regulate 
metabolic enzymes, in which case 
the cognate ligand may be the 
substrate for the enzyme in question 
or a closely related compound; in 
this capacity, MarR proteins may 
control genes involved in degradation 
of environmental toxins. Ligands 
are commonly small phenolic 
compounds, although metal ions and 
small peptides have also been shown 
to bind specific MarR homologs. As 
noted above, in addition to response 
to small molecule ligands, some MarR 
homologs respond to oxidative stress 
by oxidation of specific cysteine 
residues.  
You mentioned virulence genes. 
How do MarR proteins contribute to 
pathogenicity? MarR homologs are 
exceptionally well suited as regulators 
of virulence genes in pathogenic 
bacteria because they can respond 
to the environmental changes that 
are associated with occupancy 
of the new ecological niche. For 
example, many human pathogens 
(e.g., Salmonella and Staphylococcus) 
utilize MarR homologs such as SlyA 
and SarZ as central regulators of 
virulence gene expression, with 
the transcription factor responding 
to either small molecule ligands or 
redox conditions. In plant pathogens 
such as Erwinia, the MarR homolog 
named PecS plays a key role in 
virulence gene expression, including 
expression of enzymes responsible 
for the maceration of plant tissue that characterizes disease progression. 
Other MarR homologs may contribute 
to virulence by specifically controlling 
expression of antibiotic efflux pumps, 
as already noted.
What do MarR proteins look like 
and how do they bind DNA? MarR 
homologs are winged helix-turn-helix 
(wHTH) DNA-binding proteins that 
exist as dimers and bind palindromic 
sequences within cognate promoters 
(Figure 1). The proteins generally 
have a triangular shape with pseudo-
two-fold symmetry. The amino- and 
carboxy-terminal helices interdigitate 
to create a dimerization interface 
that dictates the distance between 
the DNA recognition helices, thus 
controlling DNA-binding affinity. 
The DNA-binding domains usually 
make few direct contacts with each 
other. The recognition helix of the 
wHTH domain binds the DNA major 
groove while the wing contacts 
the adjacent minor groove. MarR 
proteins associate with 16–20 bp 
inverted repeats, and cognate sites 
may comprise a single palindrome or 
multiple adjacent inverted repeats. 
The spacing between DNA half-
sites places two consecutive major 
grooves ~34 angstroms apart on 
one face of the DNA helix; thus, the 
spacing between the two DNA binding 
domains, determined by the dimer 
interface, is critical for binding to 
cognate DNA.
How does ligand binding attenuate 
DNA binding? Ligand binding or 
cysteine oxidation results in a protein 
conformation that is incompatible 
with DNA binding. Homologs that 
bind small molecule ligands include 
proteins that regulate metabolic 
pathways and proteins that regulate 
efflux pumps, as they typically 
share substrate preferences with 
the enzymes or efflux pumps they 
regulate. Other ligands, such as 
organic hydroperoxides, may interact 
transiently with a MarR homolog 
to cause cysteine oxidation; this 
covalent modification also results 
in attenuated DNA binding due to 
conformational changes. MarR 
proteins that are regulated by cysteine 
oxidation (e.g., SarZ and OhrR) often 
function in oxidative stress responses 
and in the regulation of virulence. 
Notably, both structural studies and 
biochemical mapping have identified 
a common effector site in a cleft nestled between the dimer interface 
and the DNA-binding lobe. Occupancy 
of this site by a small molecule ligand 
or a covalent modification of cysteine 
residues may therefore either directly 
displace the DNA-binding lobe or 
modulate the dimer interface, in either 
event inducing a protein conformation 
that is unfavorable for DNA binding. 
While MarR proteins are dimers and 
theoretically feature two equivalent 
ligand-binding pockets, occupancy of 
one primary ligand-binding site may 
induce an asymmetry that precludes 
occupancy of the symmetry-related 
site, an observation that also suggests 
that filling one ligand-binding site is 
sufficient to attenuate DNA binding 
(Figure 1). Some structures reveal 
alternative ligand-binding sites, the 
physiological relevance of which 
remains uncertain.
What are the future challenges? 
MarR homologs are abundant and 
they regulate pathways that are 
critical to bacterial physiology. 
Undoubtedly, the full spectrum of 
MarR protein involvement in gene 
regulation has yet to be revealed, 
in large part because the ligands 
to which they respond are often 
unknown. A molecular understanding 
of mechanisms by which ligands 
effect regulation of gene activity is 
critical; notably, recent advances in 
identifying ligand-binding pockets 
may furnish a much needed tool 
towards identifying the ligands for 
MarR homologs for which the effector 
remains unknown. 
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